MiR-193b inhibits the growth and metastasis of renal cell carcinoma by targeting IGF1R

References

• Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387:894–906.
   PubMed Web of Science ®Google Scholar
• Morris MR, Latif F. The epigenetic landscape of renal cancer. Nat Rev Nephrol. 2017;13:47–60.
   PubMed Web of Science ®Google Scholar
• Schmidt LS, Linehan WM. Genetic predisposition to kidney cancer. Semin Oncol. 2016;43:566–574.
   PubMed Web of Science ®Google Scholar
• López IP, Rodriguez-de la Rosa L, Pais RS, et al. Differential organ phenotypes after postnatal Igf1r gene conditional deletion induced by tamoxifen in UBC-CreERT2; Igf1r fl/fl double transgenic mice. Transgenic Res. 2015;24:279–294.
   PubMed Web of Science ®Google Scholar
• Werner H, Sarfstein R. Transcriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancer. Growth Horm IGF Res. 2014;24:112–118.
   PubMed Web of Science ®Google Scholar
• Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 1993;75:59–72.
   PubMed Web of Science ®Google Scholar
• Rota LM, Albanito L, Shin ME, et al. IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors. Cancer Res. 2014;74:5668–5679.
   PubMed Web of Science ®Google Scholar
• Yamaguchi R, Harada H, Hirota K. VHL-deficient renal cancer cells gain resistance to mitochondria-activating apoptosis inducers by activating AKT through the IGF1R-PI3K pathway. Tumor Biol. 2016;37:13295–13306.
   PubMedGoogle Scholar
• Chandrasekaran K, Karolina DS, Sepramaniam S, et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int. 2012;81:617–627.
   PubMed Web of Science ®Google Scholar
• Chan CM, Lai KKY, Ng EKO, et al. Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patients. Oncol Lett. 2018;15:3273–3280.
   PubMed Web of Science ®Google Scholar
• Zhang J, Qin J, Su Y. miR-193b-3p possesses anti-tumor activity in ovarian carcinoma cells by targeting p21-activated kinase 3. Biomed Pharmacother. 2017;96:1275–1282.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhuang Q, Hu G, et al. MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p. J Cell Biochem. 2019;120:4634–4643.
   PubMed Web of Science ®Google Scholar
• Yin W, Nie Y, Chen L, et al. Deregulation of microRNA-193b affects the proliferation of liver cancer via myeloid cell leukemia-1. Oncol Lett. 2018;15:2781–2788.
   PubMed Web of Science ®Google Scholar
• Trevisani F, Ghidini M, Larcher A, et al. MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. Br J Cancer. 2016;115:1343–1350.
   PubMed Web of Science ®Google Scholar
• Solarek W, Czarnecka AM, Escudier B, et al. Insulin and IGFs in renal cancer risk and progression. Endocr Relat Cancer. 2015;22:R253–R264.
   PubMed Web of Science ®Google Scholar
• Iida M, Tsuboi K, Niwa T, et al. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer. Breast Cancer. 2019;26:272–281.
   PubMed Web of Science ®Google Scholar
• Chen B, Li Q, Zhou Y, et al. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a. Cell Cycle. 2018;17:1949–1966.
   PubMed Web of Science ®Google Scholar
• Zorea J, Prasad M, Cohen L, et al. IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer. Cell Death Dis. 2018;9:944.
   PubMed Web of Science ®Google Scholar
• Kellerer M, von Eye Corleta H, Mühlhöfer A, et al. Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer. 1995;62:501–507.
   PubMed Web of Science ®Google Scholar
• Eich ML, Tregnago AC, Faraj SF, et al. Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma. Virchows Arch. 2019;474:21–27.
   PubMed Web of Science ®Google Scholar
• Sichani MM, Yazdi FS, Moghaddam NA, et al. Prognostic value of insulin-like growth factor-I receptor expression in renal cell carcinoma. Saudi J Kidney Dis Transpl. 2010;21:69–74.
   PubMedGoogle Scholar
• Tracz AF, Szczylik C, Porta C, et al. Insulin-like growth factor-1 signaling in renal cell carcinoma. BMC Cancer. 2016;16:453
   PubMed Web of Science ®Google Scholar
• Li BF, Zhang Y, Xiao J, et al. Hsa-circ-0045714 regulates chondrocyte proliferation, apoptosis and extracellular matrix synthesis by promoting the expression of miR-193b target gene IGF1R. Hum Cell. 2017;30:311–318.
   PubMed Web of Science ®Google Scholar